Savvy Updates 7/29/24:  Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Savvy Updates 7/29/24: Abbott FS Libre 3 Sensors Warning, Dexcom Stock Plummets, T1Ds Fear GLP-1s Will Edge Out Insulin, Sleep Apnea & Retinopathy, Diamyd Fast-Tracked, Shuren Leaves FDA CDRH, T1D Moonshot Robert Oringer, Embecta Considers Sale, SmartStart’s Interactive Educational Platform

Abbott Issues Warning for Certain FreeStyle Libre 3 Sensors by Paul Heltzel for diaTribe.org, 25 July 2024. Some FreeStyle Libre 3 continuous glucose monitoring sensors could display false high readings and should be immediately discontinued, urged the manufacturer....
Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

FDA approves hybrid closed-loop insulin delivery app from CamDiab by Sean Whooley for DrugDelieveryBusiness.com, 24 May 2024. CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX,...
Savvy Updates, 8/7/23: Tandem to Integrate with G7 & Libre 2/3 by Q4/23, Eversense, Glucotrack Implantable CGM, Glytec Glucommander for Hospitals, Insulin-like Hormones & Brain Plasticity, Climate Change & T1D, Female Sexual Dysfunction & T1D, Kombucha Benefits, Mayo Clinic BEST for Diabetes Care, CKM Data, Canada Supports Do-It-Yourself Automated Insulin Delivery

Savvy Updates, 8/7/23: Tandem to Integrate with G7 & Libre 2/3 by Q4/23, Eversense, Glucotrack Implantable CGM, Glytec Glucommander for Hospitals, Insulin-like Hormones & Brain Plasticity, Climate Change & T1D, Female Sexual Dysfunction & T1D, Kombucha Benefits, Mayo Clinic BEST for Diabetes Care, CKM Data, Canada Supports Do-It-Yourself Automated Insulin Delivery

Tandem’s Control-IQ to Integrate Dexcom G7 and FreeStyle Libre 2 as announced in the Tandem Diabetes Care, Inc., Q2 2023 Earning Call, 3 August 2023. According to John Sheridan, CEO:  “We want our customers to have the benefits of the latest CGM...
Skip to content